
Shareholders approve Novozymes-Chr. Hansen merger
In Denmark, shareholders of both Novozymes and Chr. Hansen have approved the previously announced merger of the biosolutions leaders in a deal that “unleash[es] the full potential of biological solutions and [will] generate significant value for all stakeholders and society at large.” Called a “perfect match” by Novo Holdings A/S, which is the largest shareholder […]